These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2538 related items for PubMed ID: 24582757

  • 1. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
    Adeleye Y, Andersen M, Clewell R, Davies M, Dent M, Edwards S, Fowler P, Malcomber S, Nicol B, Scott A, Scott S, Sun B, Westmoreland C, White A, Zhang Q, Carmichael PL.
    Toxicology; 2015 Jun 05; 332():102-11. PubMed ID: 24582757
    [Abstract] [Full Text] [Related]

  • 2. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials.
    Food Chem Toxicol; 2008 Mar 05; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [Abstract] [Full Text] [Related]

  • 3. The long and winding road of progress in the use of in vitro data for risk assessment purposes: From "carnation test" to integrated testing strategies.
    Blaauboer BJ.
    Toxicology; 2015 Jun 05; 332():4-7. PubMed ID: 24769060
    [Abstract] [Full Text] [Related]

  • 4. Pathway Based Toxicology and Fit-for-Purpose Assays.
    Clewell RA, McMullen PD, Adeleye Y, Carmichael PL, Andersen ME.
    Adv Exp Med Biol; 2016 Jun 05; 856():205-230. PubMed ID: 27671724
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Toxicity testing in the 21st century: bringing the vision to life.
    Andersen ME, Krewski D.
    Toxicol Sci; 2009 Feb 05; 107(2):324-30. PubMed ID: 19074763
    [Abstract] [Full Text] [Related]

  • 7. Toxicity testing in the 21st century: progress in the past decade and future perspectives.
    Krewski D, Andersen ME, Tyshenko MG, Krishnan K, Hartung T, Boekelheide K, Wambaugh JF, Jones D, Whelan M, Thomas R, Yauk C, Barton-Maclaren T, Cote I.
    Arch Toxicol; 2020 Jan 05; 94(1):1-58. PubMed ID: 31848664
    [Abstract] [Full Text] [Related]

  • 8. Quantitative in vitro-to-in vivo extrapolation in a high-throughput environment.
    Wetmore BA.
    Toxicology; 2015 Jun 05; 332():94-101. PubMed ID: 24907440
    [Abstract] [Full Text] [Related]

  • 9. Profiling dose-dependent activation of p53-mediated signaling pathways by chemicals with distinct mechanisms of DNA damage.
    Clewell RA, Sun B, Adeleye Y, Carmichael P, Efremenko A, McMullen PD, Pendse S, Trask OJ, White A, Andersen ME.
    Toxicol Sci; 2014 Nov 05; 142(1):56-73. PubMed ID: 25078064
    [Abstract] [Full Text] [Related]

  • 10. Implementation challenges for designing integrated in vitro testing strategies (ITS) aiming at reducing and replacing animal experimentation.
    De Wever B, Fuchs HW, Gaca M, Krul C, Mikulowski S, Poth A, Roggen EL, Vilà MR.
    Toxicol In Vitro; 2012 Apr 05; 26(3):526-34. PubMed ID: 22269383
    [Abstract] [Full Text] [Related]

  • 11. Computational systems biology and dose-response modeling in relation to new directions in toxicity testing.
    Zhang Q, Bhattacharya S, Andersen ME, Conolly RB.
    J Toxicol Environ Health B Crit Rev; 2010 Feb 05; 13(2-4):253-76. PubMed ID: 20574901
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Behavioral toxicology in the 21st century: challenges and opportunities for behavioral scientists. Summary of a symposium presented at the annual meeting of the neurobehavioral teratology society, June, 2009.
    Bushnell PJ, Kavlock RJ, Crofton KM, Weiss B, Rice DC.
    Neurotoxicol Teratol; 2010 Feb 05; 32(3):313-28. PubMed ID: 20171276
    [Abstract] [Full Text] [Related]

  • 15. Dose-response modeling of etoposide-induced DNA damage response.
    Li Z, Sun B, Clewell RA, Adeleye Y, Andersen ME, Zhang Q.
    Toxicol Sci; 2014 Feb 05; 137(2):371-84. PubMed ID: 24241721
    [Abstract] [Full Text] [Related]

  • 16. Quantitative in vitro to in vivo extrapolation (QIVIVE): An essential element for in vitro-based risk assessment.
    Yoon M, Blaauboer BJ, Clewell HJ.
    Toxicology; 2015 Jun 05; 332():1-3. PubMed ID: 25680635
    [No Abstract] [Full Text] [Related]

  • 17. Toxicity testing in the 21st century: how will it affect risk assessment?
    Rhomberg LR.
    J Toxicol Environ Health B Crit Rev; 2010 Feb 05; 13(2-4):361-75. PubMed ID: 20574908
    [Abstract] [Full Text] [Related]

  • 18. Dose metric considerations in in vitro assays to improve quantitative in vitro-in vivo dose extrapolations.
    Groothuis FA, Heringa MB, Nicol B, Hermens JL, Blaauboer BJ, Kramer NI.
    Toxicology; 2015 Jun 05; 332():30-40. PubMed ID: 23978460
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Current standing and future prospects for the technologies proposed to transform toxicity testing in the 21st century.
    van Vliet E.
    ALTEX; 2011 Jun 05; 28(1):17-44. PubMed ID: 21311848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 127.